102 Annual Pap Smear Screening Database Maintenance Project

• Conditions: Cancer; Human Papillomavirus

• Registration Number: NCT02063152
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

This study aimed to evaluate the subsequent cancer risks, including gynecological cancers and malignancies at other sites, after the detection of screening positives and the diagnosis for primary cervical cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 1995-01
• Study First Submitted: 2014-02-10
• Study First Submitted QC: 2014-02-13
• Study First Posted: 2014-02-14
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-14
• Last Update Posted: 2017-08-17
• Primary Completion: 2020-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 300000

Inclusion Criteria

• Citizens in Taiwan
• Women who attended screening, or who were diagnosed as cervical cancer
• Women who did not attend screening for at least 6 years

Exclusion Criteria

• Women died before the follow-up initiation
• Women who had received hysterectomy before the follow-up initiation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to the cancer diagnosis or the recurrence, the death, or the last date of follow-up, whichever came first	up to 25 years

Trial Locations

Locations (1)

Taiwan Cervical Cancer Prevention Monitoring Center; 🇨🇳 Taipei, Taiwan